Advisor(s)
Jamie Hunsicker
Confirmation
1
Document Type
Poster
Location
ONU McIntosh Center; McIntosh Activities Room
Start Date
21-4-2023 11:00 AM
End Date
21-4-2023 11:50 AM
Abstract
Abstract
Problem: Less than 25% of youth that have been diagnosed with type 1 diabetes achieve glycemic target hemoglobin A1c of less than 7.5%. Pediatric patients have difficulty with treatment plans; therefore, different medical devices are more suited to the lifestyle and activities of a pediatric diabetic patient. An intervention to increase glycemic control is continuous glucose monitoring and continuous subcutaneous insulin infusions.
Purpose: The purpose of this project is to determine the effectiveness of using a continuous blood glucose monitor compared to a self-measured blood glucose device in detecting glycemic variability and improvements in hemoglobin A1c within the pediatric population diagnosed with type 1 diabetes.
Methods: This study will be a prospective, quasi-experimental design measuring hemoglobin A1c, daily glycemic variability, and legal guardian satisfaction. Participants must be at the beginning of their treatment or have no prior use of a continuous glucose monitoring device or insulin infusion device. Hemoglobin A1c will be measured regularly with blood draws every six months, glycemic variability will be determined through the glucose measurements taken during the duration of this study, and legal guardian satisfaction will be determined through a survey at the conclusion of the study.
Conclusion: The use of continuous glucose monitors may improve glycemic control and hemoglobin A1c within the pediatric type 1 diabetic population. This is in comparison to that of a self-measured blood glucose device regardless of corrective measures such as insulin. This could be a strategy to improve pediatric diabetes management and patient outcomes
Recommended Citation
Trout, Hannah, "Evolving Technology with Pediatric Diabetes" (2023). ONU Student Research Colloquium. 5.
https://digitalcommons.onu.edu/student_research_colloquium/2023/posters/5
Level of Access
Restricted to ONU Community
Restricted
Available to ONU community via local IP address and ONU login.
Evolving Technology with Pediatric Diabetes
ONU McIntosh Center; McIntosh Activities Room
Abstract
Problem: Less than 25% of youth that have been diagnosed with type 1 diabetes achieve glycemic target hemoglobin A1c of less than 7.5%. Pediatric patients have difficulty with treatment plans; therefore, different medical devices are more suited to the lifestyle and activities of a pediatric diabetic patient. An intervention to increase glycemic control is continuous glucose monitoring and continuous subcutaneous insulin infusions.
Purpose: The purpose of this project is to determine the effectiveness of using a continuous blood glucose monitor compared to a self-measured blood glucose device in detecting glycemic variability and improvements in hemoglobin A1c within the pediatric population diagnosed with type 1 diabetes.
Methods: This study will be a prospective, quasi-experimental design measuring hemoglobin A1c, daily glycemic variability, and legal guardian satisfaction. Participants must be at the beginning of their treatment or have no prior use of a continuous glucose monitoring device or insulin infusion device. Hemoglobin A1c will be measured regularly with blood draws every six months, glycemic variability will be determined through the glucose measurements taken during the duration of this study, and legal guardian satisfaction will be determined through a survey at the conclusion of the study.
Conclusion: The use of continuous glucose monitors may improve glycemic control and hemoglobin A1c within the pediatric type 1 diabetic population. This is in comparison to that of a self-measured blood glucose device regardless of corrective measures such as insulin. This could be a strategy to improve pediatric diabetes management and patient outcomes